You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

MILNACIPRAN HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Milnacipran Hydrochloride, and when can generic versions of Milnacipran Hydrochloride launch?

Milnacipran Hydrochloride is a drug marketed by Amneal Pharms and Uspharma Windlas and is included in two NDAs.

The generic ingredient in MILNACIPRAN HYDROCHLORIDE is milnacipran hydrochloride. There are twenty-eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the milnacipran hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MILNACIPRAN HYDROCHLORIDE?
  • What are the global sales for MILNACIPRAN HYDROCHLORIDE?
  • What is Average Wholesale Price for MILNACIPRAN HYDROCHLORIDE?
Drug patent expirations by year for MILNACIPRAN HYDROCHLORIDE
Recent Clinical Trials for MILNACIPRAN HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mansoura UniversityN/A
Yousra Hisham Abdel FattahN/A
AllerganPhase 4

See all MILNACIPRAN HYDROCHLORIDE clinical trials

Pharmacology for MILNACIPRAN HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for MILNACIPRAN HYDROCHLORIDE
Paragraph IV (Patent) Challenges for MILNACIPRAN HYDROCHLORIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
SAVELLA Tablets milnacipran hydrochloride 12.5 mg, 25 mg, 50 mg, and 100 mg 022256 8 2013-01-14

US Patents and Regulatory Information for MILNACIPRAN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms MILNACIPRAN HYDROCHLORIDE milnacipran hydrochloride TABLET;ORAL 205081-001 Apr 22, 2016 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Uspharma Windlas MILNACIPRAN HYDROCHLORIDE milnacipran hydrochloride TABLET;ORAL 205071-003 Jan 27, 2016 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal Pharms MILNACIPRAN HYDROCHLORIDE milnacipran hydrochloride TABLET;ORAL 205081-004 Apr 22, 2016 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Uspharma Windlas MILNACIPRAN HYDROCHLORIDE milnacipran hydrochloride TABLET;ORAL 205071-004 Jan 27, 2016 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal Pharms MILNACIPRAN HYDROCHLORIDE milnacipran hydrochloride TABLET;ORAL 205081-002 Apr 22, 2016 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal Pharms MILNACIPRAN HYDROCHLORIDE milnacipran hydrochloride TABLET;ORAL 205081-003 Apr 22, 2016 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.